Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
about
Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis.Ventricular arrhythmias in patients with newly diagnosed nonischemic cardiomyopathy: Insights from the PROLONG study.[Ventricular arrhythmias : What has been confirmed in therapy?][Device-based remote monitoring : Current evidence].Therapy optimization in patients with heart failure: the role of the wearable cardioverter-defibrillator in a real-world setting.
P2860
Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Avoiding Untimely Implantable ...... fibrillator-The PROLONG Study.
@en
type
label
Avoiding Untimely Implantable ...... fibrillator-The PROLONG Study.
@en
prefLabel
Avoiding Untimely Implantable ...... fibrillator-The PROLONG Study.
@en
P2093
P2860
P356
P1476
Avoiding Untimely Implantable ...... efibrillator-The PROLONG Study
@en
P2093
Christian Veltmann
David Duncker
Johann Bauersachs
Thorben König
P2860
P356
10.1161/JAHA.116.004512
P577
2017-01-17T00:00:00Z